Drug · DIN 02476215
SEGLUROMET
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since February 3, 2021; first marketed July 6, 2018.
- Drug Identification Number (DIN)
- 02476215
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Combinations of oral blood glucose lowering drugs A10BD
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ERTUGLIFLOZIN | 2.5 MG | |
| METFORMIN HYDROCHLORIDE | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 30, 2018: NOC 20912New Drug Submission (NDS)
Other DINs named SEGLUROMET
- DIN 02476223 · Cancelled Post Market
- DIN 02476231 · Cancelled Post Market
- DIN 02476258 · Cancelled Post Market